Comprehensive evaluation of Growth Direct Rapid Sterility for microorganism detection

Supported by:

29 May 2024

2:00pm

Shares

3

Share via

• Facebook
• Like
• Twitter
• Pinterest
• LinkedIn
• Digg
• Del
• Tumblr
• VKontakte
• Print
• Email
• Reddit
• Buffer
• Love This
• Weibo
• Pocket
• Xing
• Odnoklassniki
• WhatsApp
• Meneame
• Blogger
• Amazon
• Yahoo Mail
• Gmail
• AOL
• Newsvine
• HackerNews
• Evernote
• MySpace
• Mail.ru
• Viadeo
• Line
• Flipboard
• Comments
• Yummly
• SMS
• Viber
• Telegram
• Subscribe
• Skype
• Facebook Messenger
• Kakao
• LiveJournal
• Yammer
• Edgar
• Fintel
• Mix
• Instapaper
• Copy Link

Secure your place today

Current Rapid Sterility methods have been unable to deliver truly rapid sterility results across a large panel of challenge organisms. The Growth Direct Rapid Sterility (GDRS) system has set out to fulfil the promise of a true rapid sterility testing method across a large, diverse and challenging organism panel based on the pharmacopeia, industry literature and global pharmaceutical manufacturer’s challenge panels.

By growing the extensive panel of organisms during challenge testing, we demonstrate that GDRS provides rapid results without compromising patient safety. For example, traditional slow growing organisms, such as C.Acnes, were detected in only 56 hours and a time-to-result was shown to be only 72 hours, highlighting the incredible speed of GDRS.

Benefits of the GDRS system

GDRS is an alternative rapid, membrane filtration based test designed to deliver a time to result in as little as t-3 days and a time to detect in as little as 12 hours. It allows pharmaceutical manufacturers to quickly respond to contaminations with real-time notifications, reduces their risk by automating processes and maintains their test integrity with a closed-loop design. You’ll increase productivity, enhance data security with automation and release safe products quickly.

Overcome your existing challenges through several design parameters and results:

• Consumable design optimized for aerobic bacteria, anaerobic bacteria, yeast, and mould
• Developing a comprehensive challenge organism panel
• Stressing bugs
• Direct inoculation side by side
• Vision core technology
• Time-to-Detect (TTD) data
• Time-to-Result (TTR) data

Register today to assure your place 

OUR SPEAKER

Kayla Volis – R&D Microbiologist, Rapid Micro Biosystems

Kayla is an R&D Microbiologist for Rapid Micro Biosystems specializing in sterility testing automation.  She has successfully assisted in scaling up pharmaceutical manufacturing and supported various continuous improvement projects. Kayla earned a B.S. degree in Biotechnology from Northeastern University.

KEY LEARNING POINTS

• How to approach challenge microorganism panels in the selection of a rapid testing method
• Effectiveness of detection using the Growth Direct Rapid Sterility system
• How to stress microorganisms in a manner that is commonly accepted in the industry
• Validating alternative microorganism rapid sterility media 

FAQs

Is the webinar free? 

Yes – there is no charge to watch the webinar, either live or on-demand. 

When will the webinar take place? 

29 May 2024 at 3.00pm 

Can I watch it later? 

The webinar will become available to watch on-demand shortly after the live webinar takes place. 

What are the benefits of attending live? 

You’ll be able to ask the speakers your questions, which will be answered live in the Q&A towards the end of the session. 

How long will the webinar be? 

This webinar will last up to an hour. 

What do I need to watch this webinar? 

All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.